EQL Pharma AB (publ) (STO:EQL)

Market Cap	1.75B
Revenue (ttm)	397.94M
Net Income (ttm)	42.54M
Shares Out	29.53M
EPS (ttm)	1.41
PE Ratio	41.89
Forward PE	28.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,683
Average Volume	76,054
Open	61.50
Previous Close	61.50
Day's Range	59.10 - 62.00
52-Week Range	58.20 - 98.60
Beta	0.57
RSI	26.95
Earnings Date	Nov 5, 2025

About EQL Pharma AB

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 21
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: EQL

Financial Performance

In 2024, EQL Pharma AB's revenue was 373.52 million, an increase of 41.39% compared to the previous year's 264.17 million. Earnings were 43.12 million, an increase of 89.93%.